FDA inspection
Hubei Gedian Humanwell Pharmaceutical Co., Ltd (Huanggang Site): FDA inspection ending Nov 19, 2025
FDA inspection 1296592 · Voluntary Action Indicated (VAI) · Huanggang
Key facts
| Inspection ID | 1296592 |
|---|---|
| Firm | Hubei Gedian Humanwell Pharmaceutical Co., Ltd (Huanggang Site) |
| FEI number | 3032513278 |
| Address | No. 1 Zhiqing Road, Railway Station Economic Development Zone, Huangzhou District |
| City | Huanggang |
| Fiscal year | 2026 |
| Inspection end date | Nov 19, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data